SEP 05, 2016 8:23 AM PDT

Just another reason to avoid nicotine: tissue damage

WRITTEN BY: Kara Marker
A new study from Umea University in Sweden provides yet another reason for people to refrain from smoking. They found that nicotine, the very substance that makes tobacco products so addictive, is directly linked to inflammatory diseases, including chronic obstructive lung disease (COPD) and many others.
Credit: Ava Hosseinzadeh, Umeå University
While the right amount of inflammation protects humans from invading pathogens like bacteria and viruses, overstimulation of certain immune cells can cause excessive and dangerous inflammation. In the case of nicotine exposure, whether directly from tobacco products or by way of second-hand smoke, the drug drug activates a type of lymphocyte to release pro-inflammatory and potentially toxic compounds.

The most abundant white blood cell in the bloodstream, the neutrophil, is responsible for releasing certain chemicals at the “scene of the crime,” AKA the site of infection. Neutrophils release reactive oxygen species (ROS) and DNA Fibers called neutrophil extracellular traps (NETs) to kill pathogens. However, ROS and NETs can also be harmful to human tissue.

Nicotine causes damage to the human body by triggering neutrophils to release ROS and NETs via an acetylcholine receptor on the surface of neutrophils. A protein kinase enzyme called Akt also helps to transmit the signal from nicotine into the neutrophil. ROS production and NET release without a pathogenic cause causes tissue damage, leading to inflammatory diseases like small vessel vasculitis, arthritis, and even cancer.

Constantin Urban, associate professor and project leader at Umea University, said that the research “should be seen as one more convincing argument to quit nicotine usage in any form.” Urban and the rest of the team from Umea showed for the first time that nicotine triggers NET release.

In the future, the researchers plan to show just how much NETs animal and human neutrophils are capable of releasing in response to stimulation in the presence of nicotine. They are hopeful that their findings will eventually lead to new anti-inflammatory therapies for diseases related to tobacco usage. 

Their study was recently published in the Journal of Leukocyte Biology
 


Source: Umea University Laboratory for Molecular Infection Medicine Sweden (MIMS)
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: havin ...
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Critical Interleukin Leads to Drug Discovery
The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their ...
APR 16, 2020
Health & Medicine
APR 16, 2020
Structural Basis of Receptor Recognition by SARS-CoV-2
As mortality and infection rates rise globally, it appears that SARS-CoV-2, the virus responsible for the COVID-19 pande ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
JUN 04, 2020
Clinical & Molecular DX
JUN 04, 2020
Low T Cells Linked To High COVID Risk
  German scientists have found a link between immune cell counts and the risk of developing severe, potentially lif ...
JUN 14, 2020
Microbiology
JUN 14, 2020
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
It's easier than thought to activate immune cells that reside in the lungs and are involved in long-term immunity. Image ...
Loading Comments...